19.55
price down icon1.31%   -0.2408
 
loading
前日終値:
$19.79
開ける:
$19.76
24時間の取引高:
251.28K
Relative Volume:
0.30
時価総額:
$1.35B
収益:
$330.50M
当期純損益:
$145.42M
株価収益率:
11.85
EPS:
1.65
ネットキャッシュフロー:
$157.96M
1週間 パフォーマンス:
-4.64%
1か月 パフォーマンス:
-3.03%
6か月 パフォーマンス:
+12.24%
1年 パフォーマンス:
+18.36%
1日の値動き範囲:
Value
$19.50
$19.87
1週間の範囲:
Value
$19.50
$20.65
52週間の値動き範囲:
Value
$16.18
$22.00

Innoviva Inc Stock (INVA) Company Profile

Name
名前
Innoviva Inc
Name
セクター
Healthcare (1168)
Name
電話
(650) 238-9600
Name
住所
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Name
職員
127
Name
Twitter
Name
次回の収益日
2025-05-02
Name
最新のSEC提出書
Name
INVA's Discussions on Twitter

INVA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
INVA
Innoviva Inc
19.55 1.35B 330.50M 145.42M 157.96M 1.65
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
455.94 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
546.92 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.23 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
547.54 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
243.40 28.51B 3.81B -644.79M -669.77M -6.24

Innoviva Inc Stock (INVA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-03-07 開始されました Scotiabank Sector Outperform
2024-06-18 開始されました Cantor Fitzgerald Overweight
2022-07-20 開始されました Goldman Neutral
2017-11-20 開始されました Deutsche Bank Hold

Innoviva Inc (INVA) 最新ニュース

pulisher
Jun 15, 2025

Rhumbline Advisers Sells 9,188 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World

Jun 15, 2025
pulisher
Jun 12, 2025

FDA Grants Priority Review for Innoviva's (INVA) Zoliflodacin | - GuruFocus

Jun 12, 2025
pulisher
Jun 12, 2025

FDA Grants Priority Review for Zoliflodacin New Drug Application for the Treatment of Uncomplicated Gonorrhea and Assigns Target PDUFA Date of December 15, 2025 - Kalkine Media

Jun 12, 2025
pulisher
Jun 10, 2025

FDA reviews new gonorrhea antibiotic from Innoviva By Investing.com - Investing.com South Africa

Jun 10, 2025
pulisher
Jun 10, 2025

FDA Reviews Innoviva's (INVA) Zoliflodacin for Gonorrhea Treatment - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Innoviva Says FDA Accepts New Drug Application for Zoliflodacin - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Innoviva Specialty's gonorrhea antibiotic to undergo FDA review (INVA) - Seeking Alpha

Jun 10, 2025
pulisher
Jun 10, 2025

FDA reviews new gonorrhea antibiotic from Innoviva - Investing.com Australia

Jun 10, 2025
pulisher
Jun 10, 2025

Innoviva Specialty Therapeutics Receives FDA New Drug Application Acceptance for Zoliflodacin, a First-in-Class Oral Antibiotic for Uncomplicated Gonorrhea in Adults - BioSpace

Jun 10, 2025
pulisher
Jun 10, 2025

Innoviva (INVA) Awaits FDA Decision on New Gonorrhea Antibiotic | INVA Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 09, 2025

Transcript : Innoviva, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 01 - MarketScreener

Jun 09, 2025
pulisher
Jun 08, 2025

Innoviva: A Riddle Wrapped In A Mystery Inside An Enigma (NASDAQ:INVA) - Seeking Alpha

Jun 08, 2025
pulisher
Jun 07, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

INVA stock touches 52-week high at $21.35 amid robust gains - Investing.com Nigeria

Jun 06, 2025
pulisher
Jun 03, 2025

Innoviva to Participate in Upcoming Investor Conferences - BioSpace

Jun 03, 2025
pulisher
Jun 02, 2025

(INVA) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jun 02, 2025
pulisher
May 29, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $546,000 Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World

May 29, 2025
pulisher
May 29, 2025

Ameriprise Financial Inc. Has $2.50 Million Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World

May 29, 2025
pulisher
May 27, 2025

Innoviva, Inc. (NASDAQ:INVA) Stock Holdings Lifted by Millennium Management LLC - Defense World

May 27, 2025
pulisher
May 23, 2025

(INVA) Proactive Strategies - news.stocktradersdaily.com

May 23, 2025
pulisher
May 21, 2025

Innoviva Elects Board Members and Approves Compensation - TipRanks

May 21, 2025
pulisher
May 21, 2025

Bank of America Corp DE Decreases Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World

May 21, 2025
pulisher
May 20, 2025

ZEVTERA® (ceftobiprole), an Advanced-Generation Cephalosporin Antibiotic Now Commercially Available in the U.S. to Treat Three Types of Bacterial Infections - BioSpace

May 20, 2025
pulisher
May 20, 2025

Innoviva (INVA) Launches New Antibiotic ZEVTERA for MRSA Treatme - GuruFocus

May 20, 2025
pulisher
May 20, 2025

ZEVTERA(Ceftobiprole), An Advanced-Generation Cephalosporin Antibiotic Now Commercially Available In The U.S. To Treat Three Types Of Bacterial Infections - marketscreener.com

May 20, 2025
pulisher
May 20, 2025

Basilea announces commercial availability of antibiotic Zevtera® (ceftobiprole) in the United States - The Manila Times

May 20, 2025
pulisher
May 19, 2025

Cubist Systematic Strategies LLC Makes New $184,000 Investment in Innoviva, Inc. (NASDAQ:INVA) - Defense World

May 19, 2025
pulisher
May 17, 2025

Innoviva, Inc. (NASDAQ:INVA) Shares Bought by Northern Trust Corp - Defense World

May 17, 2025
pulisher
May 17, 2025

Comerica Bank Sells 141,150 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World

May 17, 2025
pulisher
May 14, 2025

Armata Completes Crucial Bacteriophage Trial, Lands $4.65M Defense Contract Amid Strong Q1 Results - Stock Titan

May 14, 2025
pulisher
May 12, 2025

(INVA) Investment Analysis - news.stocktradersdaily.com

May 12, 2025
pulisher
May 08, 2025

Investor Network: Innoviva, Inc. to Host Earnings Call - ACCESS Newswire

May 08, 2025
pulisher
May 08, 2025

Envestnet Asset Management Inc. Has $258,000 Stock Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World

May 08, 2025
pulisher
May 08, 2025

Innoviva, Inc. (INVA): Among Stocks with Insanely High PE Ratios Insiders Are Selling - Insider Monkey

May 08, 2025
pulisher
May 08, 2025

Innoviva Reports First Quarter 2025 Financial Results; Highlights Recent Company Progress - BioSpace

May 08, 2025
pulisher
May 07, 2025

Innoviva: Q1 Earnings Snapshot - MySA

May 07, 2025
pulisher
May 07, 2025

Innoviva Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 07, 2025
pulisher
May 07, 2025

INVA Posts Strong Q1 Results with Revenue Growth and Strategic Developments | INVA Stock News - GuruFocus

May 07, 2025
pulisher
May 03, 2025

BlackRock, Inc. Reduces Stake in Innoviva Inc: A Detailed Analysis - GuruFocus

May 03, 2025
pulisher
May 03, 2025

Wells Fargo & Company MN Purchases 10,637 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World

May 03, 2025
pulisher
May 02, 2025

Trading (INVA) With Integrated Risk Controls - news.stocktradersdaily.com

May 02, 2025
pulisher
May 02, 2025

Innoviva (NASDAQ:INVA) Stock Rating Upgraded by StockNews.com - Defense World

May 02, 2025
pulisher
Apr 26, 2025

Rep. George Whitesides Unloads Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World

Apr 26, 2025
pulisher
Apr 26, 2025

Rep. George Whitesides Sells Off Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World

Apr 26, 2025

Innoviva Inc (INVA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Innoviva Inc (INVA) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
DENNER ALEXANDER J
10% Owner
Mar 05 '25
Sale
17.63
270,374
4,766,126
6,855,451
DENNER ALEXANDER J
10% Owner
Mar 04 '25
Sale
17.63
151,175
2,665,079
7,125,825
$20.54
price down icon 0.97%
$36.03
price up icon 0.42%
$22.21
price up icon 4.88%
$97.16
price down icon 0.39%
$107.98
price up icon 0.44%
biotechnology ONC
$243.66
price down icon 0.56%
大文字化:     |  ボリューム (24 時間):